Vaccine Trials
- All
- News
- Videos
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
Russia Develops Cancer Vaccine, To Distribute For Free: Report
Russia has developed an mRNA vaccine against cancer, which will be distributed to cancer patients for free.
-
Bill Gates Calls India A "Kind Of Laboratory To Try Things", Faces Backlash
Microsoft co-founder Bill Gates has landed in hot water after referring to India as "a kind of laboratory to try things" during a podcast with LinkedIn co-founder Reid Hoffman.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
New Cancer Vaccine Offers Hope: Early Trials Of mRNA Vaccine Show Encouraging Results
Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.
-
Bharat Biotech Launches Oral Cholera Vaccine After Successful Phase 3 Trial
Bharat Biotech International Ltd on Tuesday announced the launch of Hillchol, a novel single-strain oral cholera vaccine.
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
Revolutionary Cancer Vaccine Doubles Survival Rates, Igniting New Hope
A promising new personalized mRNA vaccine for melanoma is being tested in Britain. This custom-made vaccine offers hope for a cure and is undergoing final stage trials at UCLH.
-
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India.
-
British Indian Doctor To Undertake "Ground-Breaking" Cancer Vaccine Trial
A British Indian doctor is the chief investigator of a "ground-breaking" trial of a vaccine to treat early bowel cancer for patients worldwide, following a UK-Australia collaboration between scientists and doctors.
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
-
Positive Results For Potential First Chikungunya Vaccine
French-Austrian drugmaker Valneva's vaccine candidate against chikungunya, a mosquito-borne virus that causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday.
-
One-Shot Chikungunya Vaccine Found Safe, Effective In Phase 3 Trial: Study
A single-dose vaccine for chikungunya was found safe and produced a strong immune response against the viral disease, according to the first phase 3 trial of the preventive published in The Lancet journal.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
Russia Develops Cancer Vaccine, To Distribute For Free: Report
Russia has developed an mRNA vaccine against cancer, which will be distributed to cancer patients for free.
-
Bill Gates Calls India A "Kind Of Laboratory To Try Things", Faces Backlash
Microsoft co-founder Bill Gates has landed in hot water after referring to India as "a kind of laboratory to try things" during a podcast with LinkedIn co-founder Reid Hoffman.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
New Cancer Vaccine Offers Hope: Early Trials Of mRNA Vaccine Show Encouraging Results
Modernas new cancer vaccine, mRNA-4359, shows promising results in early clinical trials. Utilizing mRNA technology, similar to its Covid-19 vaccine, this treatment primes the immune system to identify and destroy cancer cells.
-
Bharat Biotech Launches Oral Cholera Vaccine After Successful Phase 3 Trial
Bharat Biotech International Ltd on Tuesday announced the launch of Hillchol, a novel single-strain oral cholera vaccine.
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with medical care for her side effects.
-
Revolutionary Cancer Vaccine Doubles Survival Rates, Igniting New Hope
A promising new personalized mRNA vaccine for melanoma is being tested in Britain. This custom-made vaccine offers hope for a cure and is undergoing final stage trials at UCLH.
-
Bharat Biotech Begins Clinical Trials Of TB Vaccine On Adults In India
Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India.
-
British Indian Doctor To Undertake "Ground-Breaking" Cancer Vaccine Trial
A British Indian doctor is the chief investigator of a "ground-breaking" trial of a vaccine to treat early bowel cancer for patients worldwide, following a UK-Australia collaboration between scientists and doctors.
-
Oxford Scientists Launch First Human Vaccine Trials For Nipah Virus
Nipah virus is carried by fruit bats and may also be transmitted by contact with infected animals or from person to person via close contact.
-
Positive Results For Potential First Chikungunya Vaccine
French-Austrian drugmaker Valneva's vaccine candidate against chikungunya, a mosquito-borne virus that causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday.
-
One-Shot Chikungunya Vaccine Found Safe, Effective In Phase 3 Trial: Study
A single-dose vaccine for chikungunya was found safe and produced a strong immune response against the viral disease, according to the first phase 3 trial of the preventive published in The Lancet journal.
